Yanning Wang, MS

Graduate Student
University of Florida, Department of Pharmaceutical Outcomes & Policy
University of Florida
Gainesville, United States

Yanning Wang is a third-year PhD student in the Pharmaceutical Outcomes and Policy program at the University of Florida. Prior to her PhD studies, Yanning worked as a data analyst, focusing on drug overdose surveillance, prevention, and the assessment of drug policy impacts on population health. Her current research is centered on drug benefit-risk assessment and the evaluation of drug safety during pregnancy. She is also passionate about using data visualizations to enhance research communication and dissemination.

Disclosure information not submitted.

Presentation(s):

• Risk of Pregnancy Loss after Prenatal Exposure to Doxycycline: A Retrospective Cohort Study

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of explicit criteria for teratogenicity risk mitigation programs

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• Risk of Prenatal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of Scoring Weights to Prioritize Medications for Risk Management Beyond Labelling

  Monday, August 26, 2024
  2:15 PM – 2:30 PM CEST

• High Throughput Signal Identification of Drug Use in Pregnancy for Detection of Adverse Infant Outcomes

  Wednesday, August 28, 2024
  8:30 AM – 8:45 AM CEST